TOKIO MARINE ASSET MANAGEMENT CO LTD
Position in APGE — Apogee Therapeutics, Inc.
CIK 1504169
Tokyo, M0
Position in APGE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,588,886
New position
Shares Held
27,039
first reported quarter
Ownership
0.036%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#136
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOKIO MARINE ASSET MANAGEMENT CO LTD holds $19,930,268 across 16 Biotechnology names. APGE ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,895 | $4,915,143 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
This page
|
27,039 | $3,588,886 | |
| 3 | TECH |
BIO-TECHNE Corp
|
49,600 | $3,504,240 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,141 | $2,582,079 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,316 | $1,600,275 | |
| 6 | INSM |
INSMED Inc
|
12,200 | $1,300,764 | |
| 7 | RPRX |
Royalty Pharma plc
|
20,969 | $1,175,731 | |
| 8 | INCY |
Incyte Corp
|
8,230 | $932,952 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,588,886 | 27,039 | Shares | Defined | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||